New 'Alpha' radiation therapy aims to extend life for brain cancer patients
NCT ID NCT07488754
Summary
This study is testing a new, targeted radiation treatment for people with aggressive brain tumors (glioblastoma or high-grade glioma) who have already completed standard therapy. The treatment involves placing a radioactive substance directly into the brain tumor area to try to kill remaining cancer cells. Researchers hope this approach will help patients live longer and delay the cancer's return compared to current treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurosurgery, Medical University of Warsaw, Banacha 1a
RECRUITINGWarsaw, Poland, 02-097, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Neurosurgery, National Instiute of Oncology, W.K. Roentgena 5
RECRUITINGWarsaw, Poland, 02-781, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.